SE7700098L - Bedovningsmedel och forfarande for framstellning derav - Google Patents
Bedovningsmedel och forfarande for framstellning deravInfo
- Publication number
- SE7700098L SE7700098L SE7700098A SE7700098A SE7700098L SE 7700098 L SE7700098 L SE 7700098L SE 7700098 A SE7700098 A SE 7700098A SE 7700098 A SE7700098 A SE 7700098A SE 7700098 L SE7700098 L SE 7700098L
- Authority
- SE
- Sweden
- Prior art keywords
- alpha
- annostics
- procedures
- manufacture
- hydrogen atom
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 241000284708 Sarcophaga alpha Species 0.000 abstract 1
- 230000003444 anaesthetic effect Effects 0.000 abstract 1
- 150000001441 androstanes Chemical class 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 150000003128 pregnanes Chemical class 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
- C07J13/005—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 16 (17)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
- C07J3/005—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom the carbon atom being part of a carboxylic function
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0088—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing unsubstituted amino radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0094—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0007—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
- C07J5/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa not substituted in position 16
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
- C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
- C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
- C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
- C07J7/0025—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa substituted in position 16
- C07J7/003—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/001—Oxiranes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Anesthesiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Toxicology (AREA)
- Neurology (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB357/76A GB1570394A (en) | 1976-01-06 | 1976-01-06 | 11-acyloxy-3-hydroxy steroids |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE7700098L true SE7700098L (sv) | 1977-07-07 |
Family
ID=9702974
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7700098A SE7700098L (sv) | 1976-01-06 | 1977-01-05 | Bedovningsmedel och forfarande for framstellning derav |
Country Status (12)
| Country | Link |
|---|---|
| JP (1) | JPS5285159A (fr) |
| AU (1) | AU513579B2 (fr) |
| BE (1) | BE850108A (fr) |
| CA (1) | CA1084903A (fr) |
| DE (1) | DE2700267A1 (fr) |
| DK (1) | DK3577A (fr) |
| FR (1) | FR2361419A1 (fr) |
| GB (1) | GB1570394A (fr) |
| NL (1) | NL7700054A (fr) |
| NZ (1) | NZ183004A (fr) |
| SE (1) | SE7700098L (fr) |
| ZA (1) | ZA7759B (fr) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CZ300694A3 (en) * | 1993-12-02 | 1996-05-15 | Akzo Nobel Nv | Substituted 2beta-morpholinandrostane derivatives, process of their preparation, their use for preparing pharmaceutical preparations and pharmaceutical compositions containing thereof |
| GB0105772D0 (en) * | 2001-03-08 | 2001-04-25 | Sterix Ltd | Use |
| CN119192266A (zh) | 2011-10-14 | 2024-12-27 | 萨奇治疗股份有限公司 | 3,3-二取代的19-去甲孕甾烷化合物、组合物、及其用途 |
| SG10201606063RA (en) | 2012-01-23 | 2016-09-29 | Sage Therapeutics Inc | Neuroactive steroid formulations and methods of treating cns disorders |
| MX2015002252A (es) | 2012-08-21 | 2015-07-21 | Sage Therapeutics Inc | Metodos para tratar epilepsia o estado de epilepsia. |
| WO2014169831A1 (fr) | 2013-04-17 | 2014-10-23 | Sage Therapeutics, Inc. | 19-nor-hétéroaryl-stéroïdes c21-c-liés c3,3-disubstitués et procédés d'utilisation de ceux-ci |
| ES2807264T3 (es) | 2013-04-17 | 2021-02-22 | Sage Therapeutics Inc | Esteroides neuroactivos 19-nor para métodos de tratamiento |
| JP6470258B2 (ja) | 2013-04-17 | 2019-02-13 | セージ セラピューティクス， インコーポレイテッド | １９−ノルｃ３，３−ジ置換ｃ２１−ｎ−ピラゾリルステロイドおよびその使用方法 |
| WO2014169836A1 (fr) | 2013-04-17 | 2014-10-23 | Sage Therapeutics, Inc. | 19-nor-stéroïdes neuroactifs et procédés d'utilisation de ceux-ci |
| WO2015010054A2 (fr) | 2013-07-19 | 2015-01-22 | Sage Therapeutics, Inc. | Stéroïdes neuroactifs, compositions, et leurs utilisations |
| ES2848823T3 (es) | 2013-08-23 | 2021-08-12 | Sage Therapeutics Inc | Esteroides neuroactivos, composiciones y usos de los mismos |
| WO2015195962A1 (fr) | 2014-06-18 | 2015-12-23 | Sage Therapeutics, Inc. | Stéroïdes neuroactifs, leurs compositions et utilisations |
| JOP20200195A1 (ar) | 2014-09-08 | 2017-06-16 | Sage Therapeutics Inc | سترويدات وتركيبات نشطة عصبياً، واستخداماتها |
| US10577390B2 (en) | 2014-10-16 | 2020-03-03 | Sage Therapeutics, Inc. | Compositions and methods for treating CNS disorders |
| ME03809B (fr) | 2014-10-16 | 2021-04-20 | Sage Therapeutics Inc | Compositions et méthodes pour traiter des troubles du snc |
| WO2016082789A1 (fr) | 2014-11-27 | 2016-06-02 | Sage Therapeutics, Inc. | Compositions et procédés pour traiter des troubles du snc |
| WO2016123056A1 (fr) | 2015-01-26 | 2016-08-04 | Sage Therapeutics, Inc. | Compositions et méthodes pour le traitement des troubles du snc |
| EP4155314A1 (fr) | 2015-02-20 | 2023-03-29 | Sage Therapeutics, Inc. | Stéroïdes neuroactifs, compositions et leurs utilisations |
| EP3725213B1 (fr) | 2015-06-10 | 2024-12-25 | Boston Scientific Scimed, Inc. | Détection de substance corporelle par l'évaluation de la réponse photoluminescente à un rayonnement d'excitation |
| HK1258616A1 (zh) | 2016-03-08 | 2019-11-15 | Sage Therapeutics, Inc. | 神经活性类固醇、组合物、及其用途 |
| US20190233465A1 (en) * | 2016-07-11 | 2019-08-01 | Sage Therapeutics, Inc. | C7, c12, and c16 substituted neuroactive steroids and their methods of use |
| MA45599A (fr) | 2016-07-11 | 2019-05-15 | Sage Therapeutics Inc | Stéroïdes neuroactifs substitués en c17, c20 et c21 et leurs procédés d'utilisation |
| CN111741965B (zh) * | 2017-12-22 | 2024-06-25 | 萨奇治疗股份有限公司 | 治疗中枢神经系统疾病的组合物和方法 |
| IL283629B2 (en) | 2018-12-05 | 2026-03-01 | Sage Therapeutics Inc | Neuroactive steroids and methods of using them |
| CR20240234A (es) | 2019-05-31 | 2024-07-09 | Sage Therapeutics Inc | ESTEROIDES NEUROACTIVOS Y COMPOSICIONES DE ESTOS (Divisional 2021-629) |
| AU2020304673A1 (en) * | 2019-06-27 | 2022-01-20 | Sage Therapeutics, Inc. | Compositions and methods for treating CNS disorders |
| JP7787635B2 (ja) | 2019-06-27 | 2025-12-17 | セージ セラピューティクス， エルエルシー | Ｃｎｓ障害を治療するための組成物及び方法 |
| US20230257415A1 (en) * | 2019-06-27 | 2023-08-17 | Sage Therapeutics, Inc. | Compounds for treating cns disorders |
-
1976
- 1976-01-06 GB GB357/76A patent/GB1570394A/en not_active Expired
-
1977
- 1977-01-05 ZA ZA00770059A patent/ZA7759B/xx unknown
- 1977-01-05 SE SE7700098A patent/SE7700098L/ not_active Application Discontinuation
- 1977-01-05 DK DK3577A patent/DK3577A/da not_active Application Discontinuation
- 1977-01-05 DE DE19772700267 patent/DE2700267A1/de not_active Ceased
- 1977-01-05 JP JP30477A patent/JPS5285159A/ja active Pending
- 1977-01-05 NL NL7700054A patent/NL7700054A/xx not_active Application Discontinuation
- 1977-01-05 BE BE173855A patent/BE850108A/fr not_active IP Right Cessation
- 1977-01-05 AU AU21065/77A patent/AU513579B2/en not_active Expired
- 1977-01-05 FR FR7700171A patent/FR2361419A1/fr active Granted
- 1977-01-05 CA CA269,161A patent/CA1084903A/fr not_active Expired
- 1977-01-06 NZ NZ183004A patent/NZ183004A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NL7700054A (nl) | 1977-07-08 |
| DK3577A (da) | 1977-07-07 |
| FR2361419A1 (fr) | 1978-03-10 |
| GB1570394A (en) | 1980-07-02 |
| AU513579B2 (en) | 1980-12-11 |
| BE850108A (fr) | 1977-07-05 |
| NZ183004A (en) | 1980-03-05 |
| AU2106577A (en) | 1978-07-13 |
| DE2700267A1 (de) | 1977-07-14 |
| ZA7759B (en) | 1978-02-22 |
| FR2361419B1 (fr) | 1980-04-04 |
| CA1084903A (fr) | 1980-09-02 |
| JPS5285159A (en) | 1977-07-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE7700098L (sv) | Bedovningsmedel och forfarande for framstellning derav | |
| BG28060A3 (en) | Method of transforming of cis- hexahydrodibenzo (beta,alpha) pyran- 9-ones in trans- hexahydrodibenzo (beta,alpha) pyran- 9- ones | |
| GB1534823A (en) | Dental chairs or like patient supporting devices | |
| AU508224B2 (en) | 9 21-dihalogeno-11 17 -dihydroxy-6 -fluro-16-methyl-pregna-1,4-diene-3,20-diones | |
| ATE18671T1 (de) | 17,17-bis(substituiert thio)-3-keto-androstene und pharmazeutische zusammensetzungen. | |
| BG28849A3 (bg) | Метод за получаване на гамапирони | |
| AU4140585A (en) | 1,4-dihydropyridine-3-carboxylates and salts thereof | |
| NL7700293A (nl) | Tandartsstoel. | |
| BG34452A3 (en) | Method for obtaining cephalosporines | |
| PT86228A (de) | Verfahren zur herstellung von 6alpha,9alpha-difluor-11beta,17alpha-dihydroxy-16alpha-methil-4-pregnen-3,20-dion und dessen derivate | |
| BG33735A3 (bg) | Метод за получаване на заместени в 17-та позиция стероиди от прегнановия ред | |
| GB1492581A (en) | Medical and surgical dressings | |
| DK133382B (da) | Analogifremgangsmåde til fremstilling af 6alfa,9alfa-diflour-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-dien-3,20-dion-17,21-diacetat. | |
| SU561834A1 (ru) | Быстроразъемное соединение | |
| BG36633A3 (en) | Method for preparing 3- hydroxycephalosporines | |
| FI842894A0 (fi) | Foerfarande foer framstaellning av (8s)-8-fluoroerytromyciner. | |
| IT1149935B (it) | Uso farmacologico del 6-cloro-17-idrossi 1 alfa,2 alfa-metilpregna 4,6-dien-3,20-dione | |
| IE810185L (en) | N-phenyl-n'-cyano-o-phenylisoureas | |
| IE37597L (en) | 21-fluoro pregnanes. | |
| CA490536A (fr) | Chaise de dentiste | |
| ES465550A1 (es) | Procedimiento para la obtencion de halogenopregnadienos. | |
| SU711556A1 (ru) | Цифровой генератор функции | |
| SU666320A1 (ru) | Зубчата эластична муфта м.с.тривайло | |
| IT1239719B (it) | Uso dell'anticorpo monoclonale sp-2 nella diagnostica clinica ed il monitoraggio del progredire dell'infezione hiv | |
| FR2283100A1 (fr) | Melange a base de platre |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NAV | Patent application has lapsed |
Ref document number: 7700098-2 |